Meeting
2022 ASCO Quality Care Symposium
Disparities in overall survival (OS) outcomes based on treating facility volume in pancreatic neuroendocrine tumors.
Authors
Sri Harsha Tella
Mayo Clinic, Rochester, MN
Sri Harsha Tella, Anuhya Kommalapati, Aakash Desai, Patrick Walsh McGarrah, Timothy J. Hobday, Thorvardur Ragnar Halfdanarson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Cancer Outcome Disparities
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 150)
DOI
10.1200/JCO.2022.40.28_suppl.150
Abstract #
150
Poster Bd #
E19
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Understanding causes of racial/ethnic survival disparity in 47,178 patients with colorectal cancer: A quantitative evaluation of molecular, socioeconomic, and clinical covariates.
First Author: Mahmoud M.G. Yousef
First Author: Olivia French Gordon
Poster
2023 ASCO Annual Meeting
Social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival.
First Author: Elizabeth Rodriguez
Poster
2023 ASCO Genitourinary Cancers Symposium
Implications of ethnicity among patients with metastatic renal cell carcinoma (mRCC) treated with nivolumab plus ipilimumab (nivo/ipi).
First Author: Sally Leong